This inventor holds 10 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010-2025.
Location History:
- Reston, VA (US) (2010 - 2013)
- Potomac, MD (US) (2017 - 2024)
Company Filing History:
Years Active: 2010-2025
Title: Innovations of Qiong J Wang in Cancer Treatment
Introduction
Qiong J Wang is a prominent inventor based in Potomac, MD (US), known for his significant contributions to cancer research and treatment. With a total of 10 patents, his work focuses on developing innovative T cell receptors that target specific cancer-related antigens.
Latest Patents
One of his latest patents is for Anti-mutated KRAS T cell receptors. This invention discloses an isolated or purified T cell receptor (TCR) that has antigenic specificity for an HLA-A11-restricted epitope of mutated Kirsten rat sarcoma viral oncogene homolog (KRAS), Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog (NRAS), or Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS). The patent also includes related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. Additionally, it outlines methods for detecting cancer in mammals and methods for treating or preventing cancer.
Another significant patent by Qiong J Wang is for Anti-thyroglobulin T cell receptors. This synthetic T cell receptor (TCR) has antigenic specificity for an HLA-A2-restricted epitope of thyroglobulin (TG). Similar to his previous patent, it provides related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and populations of cells. It also includes antibodies and pharmaceutical compositions related to the TCRs, along with methods for detecting and treating cancer in mammals.
Career Highlights
Qiong J Wang is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to contribute significantly to the field of immunotherapy and cancer treatment.
Collaborations
Some of his notable coworkers include James C Yang and Zhiya Yu, who have collaborated with him on various research projects aimed at advancing cancer therapies.
Conclusion
Qiong J Wang's innovative work in developing T cell receptors for cancer treatment showcases his dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science and providing new avenues for cancer therapy.